Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Apomorphine reduces subthalamic neuronal entropy in parkinsonian patients.

Lafreniere-Roula M, Darbin O, Hutchison WD, Wichmann T, Lozano AM, Dostrovsky JO.

Exp Neurol. 2010 Oct;225(2):455-8. doi: 10.1016/j.expneurol.2010.07.016. Epub 2010 Jul 24.

2.

Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson's disease.

Levy R, Dostrovsky JO, Lang AE, Sime E, Hutchison WD, Lozano AM.

J Neurophysiol. 2001 Jul;86(1):249-60.

3.

Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus.

Benedetti F, Colloca L, Torre E, Lanotte M, Melcarne A, Pesare M, Bergamasco B, Lopiano L.

Nat Neurosci. 2004 Jun;7(6):587-8. Epub 2004 May 16.

PMID:
15146189
4.

Deep brain stimulation of the subthalamic nucleus reestablishes neuronal information transmission in the 6-OHDA rat model of parkinsonism.

Dorval AD, Grill WM.

J Neurophysiol. 2014 May;111(10):1949-59. doi: 10.1152/jn.00713.2013. Epub 2014 Feb 19.

5.

Deep brain stimulation reduces neuronal entropy in the MPTP-primate model of Parkinson's disease.

Dorval AD, Russo GS, Hashimoto T, Xu W, Grill WM, Vitek JL.

J Neurophysiol. 2008 Nov;100(5):2807-18. doi: 10.1152/jn.90763.2008. Epub 2008 Sep 10.

6.

Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine.

Lozano AM, Lang AE, Levy R, Hutchison W, Dostrovsky J.

Ann Neurol. 2000 Apr;47(4 Suppl 1):S141-6.

PMID:
10762141
7.

Multisecond oscillations in the subthalamic nucleus: effects of apomorphine and dopamine cell lesion.

Allers KA, Kreiss DS, Walters JR.

Synapse. 2000 Oct;38(1):38-50.

PMID:
10941139
8.

Stimulation of the subthalamic nucleus engages the cerebellum for motor function in parkinsonian rats.

Sutton AC, O'Connor KA, Pilitsis JG, Shin DS.

Brain Struct Funct. 2015 Nov;220(6):3595-609. doi: 10.1007/s00429-014-0876-8. Epub 2014 Aug 15.

PMID:
25124274
9.

MK801 and amantadine exert different effects on subthalamic neuronal activity in a rodent model of Parkinson's disease.

Allers KA, Bergstrom DA, Ghazi LJ, Kreiss DS, Walters JR.

Exp Neurol. 2005 Jan;191(1):104-18.

PMID:
15589517
10.
11.

Subthalamic oscillatory activities at beta or higher frequency do not change after high-frequency DBS in Parkinson's disease.

Foffani G, Ardolino G, Egidi M, Caputo E, Bossi B, Priori A.

Brain Res Bull. 2006 Mar 31;69(2):123-30. Epub 2005 Dec 13.

PMID:
16533660
12.

Dopamine-dependent high-frequency oscillatory activity in thalamus and subthalamic nucleus of patients with Parkinson's disease.

Kane A, Hutchison WD, Hodaie M, Lozano AM, Dostrovsky JO.

Neuroreport. 2009 Nov 25;20(17):1549-53. doi: 10.1097/WNR.0b013e32833282c8.

PMID:
19829159
13.

Activity parameters of subthalamic nucleus neurons selectively predict motor symptom severity in Parkinson's disease.

Sharott A, Gulberti A, Zittel S, Tudor Jones AA, Fickel U, Münchau A, Köppen JA, Gerloff C, Westphal M, Buhmann C, Hamel W, Engel AK, Moll CK.

J Neurosci. 2014 Apr 30;34(18):6273-85. doi: 10.1523/JNEUROSCI.1803-13.2014.

14.

Deep brain stimulation of both subthalamic nucleus and internal globus pallidus restores intracortical inhibition in Parkinson's disease paralleling apomorphine effects: a paired magnetic stimulation study.

Pierantozzi M, Palmieri MG, Mazzone P, Marciani MG, Rossini PM, Stefani A, Giacomini P, Peppe A, Stanzione P.

Clin Neurophysiol. 2002 Jan;113(1):108-13.

PMID:
11801431
15.

Nonlinear temporal organization of neuronal discharge in the basal ganglia of Parkinson's disease patients.

Lim J, Sanghera MK, Darbin O, Stewart RM, Jankovic J, Simpson R.

Exp Neurol. 2010 Aug;224(2):542-4.

PMID:
20653074
16.

Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease.

Priori A, Foffani G, Pesenti A, Tamma F, Bianchi AM, Pellegrini M, Locatelli M, Moxon KA, Villani RM.

Exp Neurol. 2004 Oct;189(2):369-79.

PMID:
15380487
17.

Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus.

De Gaspari D, Siri C, Landi A, Cilia R, Bonetti A, Natuzzi F, Morgante L, Mariani CB, Sganzerla E, Pezzoli G, Antonini A.

J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):450-3.

18.

The subthalamic activity and striatal monoamine are modulated by subthalamic stimulation.

Yamamoto T, Uchiyama T, Sakakibara R, Taniguchi J, Kuwabara S.

Neuroscience. 2014 Feb 14;259:43-52. doi: 10.1016/j.neuroscience.2013.11.034. Epub 2013 Nov 27.

PMID:
24291727
19.

Dopamine-dependent non-linear correlation between subthalamic rhythms in Parkinson's disease.

Marceglia S, Foffani G, Bianchi AM, Baselli G, Tamma F, Egidi M, Priori A.

J Physiol. 2006 Mar 15;571(Pt 3):579-91. Epub 2006 Jan 12.

20.

Subdyskinetic apomorphine responses in globus pallidus and subthalamus of parkinsonian patients: lack of clear evidence for the 'indirect pathway'.

Stefani A, Bassi A, Mazzone P, Pierantozzi M, Gattoni G, Altibrandi MG, Giacomini P, Peppe A, Bernardi G, Stanzione P.

Clin Neurophysiol. 2002 Jan;113(1):91-100.

PMID:
11801429

Supplemental Content

Support Center